New developments in the management of COPD: clinical utility of indacaterol 75 μg

Chronic obstructive pulmonary disease (COPD) is a global health challenge and a major cause of mortality worldwide. Bronchodilators, particularly long-acting β(2)-agonists and long-acting antimuscarinic agents, used singly or in combination, aim to improve lung function, reduce symptoms, prevent exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiropoulos, Paschalis, Archontogeorgis, Kostas, Nena, Evangelia, Bouros, Demosthenes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862584/
https://www.ncbi.nlm.nih.gov/pubmed/24353414
http://dx.doi.org/10.2147/COPD.S24940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862584/
https://www.ncbi.nlm.nih.gov/pubmed/24353414
http://dx.doi.org/10.2147/COPD.S24940

Ejemplares similares